arrow
P

Pierre Gourdy

Toulouse University Hospital
H指数:59
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

P458 - LBA_ECE_1238 - Prevalence, vascular risk factors and complications of metabolic syndrome in a population of people living with type 1 diabetes: results from the French SFDT1 cohort

P458 - LBA_ECE_1238 - 代谢综合征在1型糖尿病患者人群中的患病率、血管危险因素及并发症:法国SFDT1队列研究的结果

2026-08-100
OAAI
Maturity Onset Diabetes of the Young (MODY): French National Diagnosis and Care Protocol (PNDS, Protocole National de Diagnostic et de Soins)

青年成熟期发病糖尿病(MODY):法国国家诊断与治疗方案(PNDS,Protocole National de Diagnostic et de Soins)

2026-03-310
OAAI
Salivary microbiota signatures of periodontitis are associated with CGM-derived short-term glycaemic control in adults with type 1 diabetes: a pilot study

牙周炎患者的唾液微生物特征与CGM衍生的短期血糖控制水平相关:一项初步研究

2026-03-130
OAAI
Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolism

核激素敏感脂肪酶调节脂肪组织质量和脂肪细胞代谢

2025-10-230
OAAI
Management of patients with type 2 diabetes and MASLD: an overview and joint statement

2型糖尿病和MASLD患者的管理:概述与联合声明

2025-10-150
PRE
Efficiency of Gla-300 versus Gla-100 Across Age Groups in People Living with Type 2 Diabetes in France: A Post Hoc Analysis of an Observational Longitudinal Study

法国2型糖尿病人群中不同年龄组Gla-300与Gla-100的疗效比较:一项观察性纵向研究的事后分析

2025-10-090
OA
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial

每周一次IcoSema与每日多次胰岛素注射在2型糖尿病管理中的比较(COMBINE 3):一项开放标签、多中心、治疗至目标、非劣效性、随机、3a期临床试验

2025-06-040
PRE
Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling

肝脏基因表达及其在肝脂肪变性中的重塑由PI3Kα依赖性肝细胞信号通路调控

2025-04-140
OA
Heterogeneity of glycaemic phenotypes in type 1 diabetes

1型糖尿病患者血糖表型的异质性

2024-05-232
OAAI
The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
2023-09-0125
OAAI
Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study
2023-03-2510
OA